Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development

Keyphrases

• Mammalian Target of Rapamycin (mTOR) 100%
• Cortical Malformation 100%
• Epileptic Encephalopathy 100%
• Malformations of Cortical Development 100%
• Epilepsy 50%
• MTOR Inhibitor 50%
• Epileptogenesis 50%
• Mammalian Target of Rapamycin Signaling Pathway 50%
• Tuberous Sclerosis Complex 25%
• Mouse Model 25%
• Molecular Mechanism 25%
• Clinical Trials 25%
• Signaling Pathway 25%
• Genetic Studies 25%
• Cellular Mechanisms 25%
• Current Treatment 25%
• Pathogenic Mechanism 25%
• Common Cause 25%
• New Drug Targets 25%
• Gene Regulating 25%
• Epilepsy in children 25%
• Drug Seizures 25%
• Antiseizure 25%
• Antiepileptogenic 25%
• Focal Cortical Dysplasia 25%
• Drug-resistant Epilepsy 25%
• Hemimegalencephaly 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Mammalian Target of Rapamycin 100%
• Congenital Malformation 100%
• Brain Disease 100%
• Cortical Dysplasia 100%
• Mammalian Target of Rapamycin Inhibitor 50%
• Epilepsy 50%
• Epileptogenesis 50%
• Clinical Trial 25%
• Mouse Model 25%
• Tuberous Sclerosis 25%
• Alexander Disease 25%
• Drug Resistant Epilepsy 25%

Neuroscience

• Mammalian Target of Rapamycin 100%
• Brain Disease 100%
• Cortical Malformation 80%
• Epileptogenesis 40%
• Epilepsy 40%
• Cell Signaling 20%
• Tuberous Sclerosis 20%
• Alexander Disease 20%
• Dysplasia 20%
• Genetics 20%
• Drug Resistant Epilepsy 20%